Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial

PURPOSE: A phase III trial assessed the efficacy of palonosetron plus dexamethasone given once in preventing acute and delayed chemotherapy-induced nausea and vomiting (CINV) following a broad range of moderately emetogenic chemotherapy (MEC) regimens. METHODS: This multicentre, randomized, open-lab...

Descripción completa

Detalles Bibliográficos
Autores principales: Celio, Luigi, Frustaci, Sergio, Denaro, Angela, Buonadonna, Angela, Ardizzoia, Antonio, Piazza, Elena, Fabi, Alessandra, Capobianco, Alba Maria, Isa, Luciano, Cavanna, Luigi, Bertolini, Alessandro, Bichisao, Ettore, Bajetta, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128271/
https://www.ncbi.nlm.nih.gov/pubmed/20574663
http://dx.doi.org/10.1007/s00520-010-0941-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128271/
https://www.ncbi.nlm.nih.gov/pubmed/20574663
http://dx.doi.org/10.1007/s00520-010-0941-7

Ejemplares similares